The Hereditary Cancer Testing Market is witnessing a paradigm shift, driven by rapid technological advancements and a growing public awareness of genetic disorders. With a market size of approximately USD 8.96 billion in 2024 and a projected increase to USD 25.19 billion by 2035, this sector is set for significant gains, with a compound annual growth rate (CAGR) of 9.85%. Such growth reflects...